TGTX
Tg Therapeutics
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: TGTX
- PEG Ratio
As of Jul 23, 2026, TGTX's PEG ratio of 0.02 reflects its valuation relative to its growth. This value reflects a P/E ratio of 17.24 measured against EPS growth of 1092.6%.
TGTX PEG ratio history
Tg Therapeutics's three years historical PEG ratio averages out to 0.69. Compared to historical data, TGTX's 0.02 PEG ratio represents a decrease of 97%. TGTX reached its maximum PEG ratio of 2.42 during the Dec 2024 quarter over the past three years. The Sep 2025 quarter had the bottom reading at 0, indicating the most optimal growth-adjusted valuation.
Tg Therapeutics PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.01 | 9.62 | 1,837.5% |
| 2024 | 2.42 | 188.13 | 77.8% |
| 2023 | 1.8 | 189.78 | 105.5% |
| 2022 | N/A | N/A | 37.3% |
| 2021 | N/A | N/A | -8.7% |
| 2020 | N/A | N/A | -23.5% |
| 2019 | N/A | N/A | 14.8% |
| 2018 | N/A | N/A | -20.4% |
| 2017 | N/A | N/A | -19.4% |
| 2016 | N/A | N/A | -15.9% |
| 2015 | N/A | N/A | 15.9% |
| 2014 | N/A | N/A | -102.5% |
| 2013 | N/A | N/A | 41.3% |
| 2012 | N/A | N/A | -213.6% |
| 2011 | N/A | N/A | -102.6% |
Tg Therapeutics PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.01 | 10.32 | 1,092.6% |
| Dec 2025 | 0.01 | 9.62 | 1,837.5% |
| Sep 2025 | 0 | 11.77 | 3,511.1% |
| Jun 2025 | N/A | 87.78 | -39.7% |
| Mar 2025 | N/A | 146.04 | -6.9% |
| Dec 2024 | 2.42 | 188.13 | 77.8% |
| Sep 2024 | N/A | N/A | 76.9% |
| Jun 2024 | 0.18 | 26.16 | 146.9% |
| Mar 2024 | 0.43 | 52.45 | 120.6% |
| Dec 2023 | 1.8 | 189.78 | 105.5% |
| Sep 2023 | N/A | N/A | 78% |
| Jun 2023 | N/A | N/A | 32.9% |
| Mar 2023 | N/A | N/A | 42.4% |
| Dec 2022 | N/A | N/A | 37.3% |
| Sep 2022 | N/A | N/A | 33.2% |
TGTX average PEG ratio chart
Measured against past performance, TGTX's PEG ratio comes in under the 3, 5 and 10-year averages.
PEG comparison
With a PEG of 0.02, TGTX stands below the Healthcare sector and the industry average. In comparison with its Healthcare sector average of 0.54, Tg Therapeutics's PEG is 96% lower.
TGTX EPS growth
TGTX Price vs fair value
TGTX PEG vs peers
| Stock name | PEG ratio | Market cap |
|---|---|---|
| TGTX Tg Therapeutics Inc | 0.02 | $8.58B |
| ALKS Alkermes plc | N/A | $8.82B |
| NERV Minerva Neurosciences Inc | N/A | $188.22M |
Frequently asked questions
What is Tg Therapeutics's PEG ratio?
TGTX's Jul 23, 2026 PEG ratio comes in at 0.02.
What is the 3-year average PEG ratio for Tg Therapeutics (TGTX)?
Over the last 3 years, TGTX's PEG ratio has centered around 0.69.
What is the 5-year average PEG ratio for Tg Therapeutics (TGTX)?
Over the last 5 years, TGTX's PEG ratio has centered around 0.69.
What is the highest PEG ratio for TGTX?
In the last three years, TGTX's peak PEG ratio of 2.42 was recorded in the Dec 2024 quarter.
How does the current PEG ratio for TGTX compare to its historical average?
Currently, TGTX's PEG ratio is 97% lower than its 3-year historical average.
Why is Tg Therapeutics's PEG ratio so low?
Rapid earnings expansion combined with a reasonable valuation yields TGTX a PEG ratio of 0.02.
How is TGTX's PEG ratio calculated (Tg Therapeutics PEG ratio formula)?
To calculate the PEG ratio, take the company's PE ratio and divide by its EPS growth rate (YoY TTM). As of Jul 23, 2026, Tg Therapeutics carries a P/E ratio of 17.24. Earnings grew at 1092.6% over the TTM period ending Mar 2026. Applying the formula, this yields a price to earnings growth ratio of 0.02. PEG RATIO(0.02) = PE RATIO(17.24) / EPS GROWTH(1092.6%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.